Regulatory T cell-mediated transplantation tolerance

Immunologic Research

Volumn 33, Issue 3, 2005, Pages 195-212

  Bharat, Ankit ^a   Fields, Ryan Courtney ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive immune response; Antigen presentation; Infectious tolerance; Lung transplantation; Regulatory cells; T cells; Transplantation tolerance

Indexed keywords

CALCINEURIN INHIBITOR; CALCITRIOL; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; T LYMPHOCYTE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ALLOGRAFT; ALLOTRANSPLANTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BRONCHIOLITIS OBLITERANS; CELL INTERACTION; CELL PROLIFERATION; CELLULAR IMMUNITY; DENDRITIC CELL; GENE EXPRESSION; GENE MUTATION; GRAFT REJECTION; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOLECULAR BIOLOGY; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE;

EID: 32244438621     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:33:3:195     Document Type: Review

References (153)

1. Nishizuka Y, Sakakura T: Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 1969;166(906):753-755.
2. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y: Prevention of postthymectomy autoimmune thyroiditis in mice. Lab Invest 1976;34(6):601-605.
3. Sakaguchi S, Takahashi T, Nishizuka Y: Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982;156(6):1565- 1576.
4. Sakaguchi S, Takahashi T, Nishizuka Y: Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med 1982;156(6):1577-1586.
5. Smith H, Sakamoto Y, Kasai K, Tung KS: Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J Immunol 1991;147(9):2928-2933.
6. Gershon RK, Maurer PH, Merryman CF: A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. Proc Natl Acad Sci USA 1973;70(1):250-254.
7. Gershon RK, Cohen P, Hencin R, Liebhaber SA: Suppressor T cells. J Immunol 1972;108(3):586-590.
8. Gershon RK, Kondo K: Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970;18(5):723-737.
9. Gershon RK, Liebhaber S: Ryu S: T-cell regulation of T-cell responses to antigen. Immunology 1974;26(5):909-923.
10. Gershon RK, Lance EM, Kondo K: Immuno-regulatory role of spleen localizing thymocytes. J Immunol 1974;112(2):546-554.
11. Green DR, Webb DR: Saying the 'S' word in public. Immunol Today 1993;14(11):523-525.
12. Hall BM, Pearce NW, Gurley KE, Dorsch SE: Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990;171(1):141-157.
13. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155(3):1151-1164.
14. Gilliet M, Liu YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002;195(6):695-704.
15. Zhou J, Carr RI, Liwski RS, Stadnyk AW, Lee TD: Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol 2001;167(1):107-113.
16. Ciubotariu R, Colovai AI, Pennesi G, et al: Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. J Immunol 1998;161(10):5193-5202.
17. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L: Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000;6(7):782-789.
18. Wang R, Wang-Zhu Y, Grey H: Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci USA 2002;99(4):2181-2186.
19. Zeng D, Lewis D, Dejbakhsh-Jones S, et al: Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999;189(7):1073-1081.
20. Seino KI, Fukao K, Muramoto K, et al: Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001;98(5):2577-2581.
21. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 2001;167(3):1245-1253.
22. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193(11):1285-1294.
23. Levings MK, Sangregorio R, Roncarolo MG: Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193(11):1295-1302.
24. Stephens LA, Mottet C, Mason D, Powrie F: Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001;31(4):1247-1254.
25. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193(11):1303-1310.
26. Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991;352(6336):621-624.
27. Almeida AR, Legrand N, Papiernik M, Freitas AA: Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002;169(9):4850-4860.
28. Suzuki H, Zhou YW, Kato M, Mak TW, Nakashima I: Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J Exp Med 1999;190(11):1561-1572.
29. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995;3(4):521-530.
30. Malek TR, Yu A, Vincek V, Scibelli P, Kong L: CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002;17(2):167-178.
31. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ: Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 2002;196(6):851-857.
32. Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
33. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3(1):33-41.
34. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001;31(4):1122-1131.
35. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188(2):287-296.
36. Fehr T, Takeuchi Y, Kurtz J, Wekerle T, Sykes M: Early regulation of CD8 T cell alloreactivity by CD4(+)CD25(-)T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8(+) T cells, precluding a role for sustained regulation. Eur J Immunol 2005;35(9):2679-2690.
37. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H: Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 2002;168(11):5558-5565.
38. Unger WW, Jansen W, Wolvers DA, van Halteren AG, Kraal G, Samsom JN: Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells. Int Immunol 2003;15(6):731-739.
39. Bluestone JA, Abbas AK: Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003;3(3):253-257.
40. Sakaguchi S: Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005;6(4):345-352.
41. Arch RH: Function of tumor necrosis factor receptor family members on regulatory T cells. Immunol Res 2005;32(1-3):15-30.
42. Taams LS, Vukmanovic-Stejic M, Smith J, et al: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002;32(6):1621-1630.
43. Takahashi T, Tagami T, Yamazaki S, et al: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192(2):303-310.
44. Takahashi T, Kuniyasu Y, Toda M, et al: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10(12):1969-1980.
45. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S: Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3(2):135-142.
46. Baecher-Allan C, Viglietta V, Hafler DA: Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 2002;169(11):6210-6217.
47. LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176(1):177-186.
48. Fritzsching B, Oberle N, Eberhardt N, et al: Cutting edge: in contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol 2005;175(1):32-36.
49. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197(4):403-411.
50. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299(5609):1033-1036.
51. Brunkow ME, Jeffery EW, Hjerrild KA, et al: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27(1):68-73.
52. Chatila TA, Blaeser F, Ho N, et al: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106(12):R75-81.
53. Godfrey VL, Wilkinson JE, Russell LB: X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991;138(6):1379-1387.
54. Powell BR, Buist NR, Stenzel P: An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982;100(5):731-737.
55. Gambineri E, Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003;15(4):430-435.
56. Bennett CL, Christie J, Ramsdell F, et al: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27(1):20-21.
57. Wildin RS, Ramsdell F, Peake J, et al: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27(1):18-20.
58. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4(4):330-336.
59. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299(5609):1057-1061.
60. Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4(4):337-342.
61. Tommasini A, Ferrari S, Moratto D, et al: X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clin Exp Immunol 2002;130(1):127-130.
62. Albert MH, Liu Y, Anasetti C, Yu XZ: Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol 2005;35:2598-2607.
63. Chai JG, Xue SA, Coe D, et al: Regulatory T cells, derived from naive CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 2005;79(10):1310-1316.
64. Chen W, Jin W, Hardegen N, et al: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198(12):1875-1886.
65. Baratelli F, Lin Y, Zhu L, et al: Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells. J Immunol 2005;175(3):1483-1490.
66. Hong J, Li N, Zhang X, Zheng B, Zhang JZ. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci USA 2005;102(18):6449-6454.
67. Walker MR, Kasprowicz DJ, Gersuk VH, et al: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003;112(9):1437-1443.
68. Liang S, Alard P, Zhao Y, Parnell S, Clark SL, Kosiewicz MM: Conversion of CD4+CD25- cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005;201(1):127-137.
69. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C: Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998;10(4):371-378.
70. Yvon ES, Vigouroux S, Rousseau RF, et al: Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood 2003;102(10):3815-3821.
71. Derbinski J, Schulte A, Kyewski B, Klein L: Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001;2(11):1032-1039.
72. Jordan MS, Boesteanu A, Reed AJ, et al: Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2(4):301-306.
73. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 2002;196(2):247-253.
74. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002;196(2):255-260.
75. Stassen M, Fondel S, Bopp T, et al: Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 2004;34(5):1303-1311.
76. Groux H, O'Garra A, Bigler M, et al: A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997;389(6652):737-742.
77. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo MG: IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001;166(9):5530-5539.
78. Wakkach A, Cottrez F, Groux H: Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol 2001;167(6):3107-3113.
79. Barrat FJ, Cua DJ, Boonstra A, et al: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002;195(5):603-616.
80. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA, Jr., Weiner HL: Oral tolerance in myelin basic protein T cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996;93(1):388-391.
81. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL: IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 1998;28(9):2780-2790.
82. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996;98(1):70-77.
83. Teitelbaum D, Arnon R, Sela M: Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc Natl Acad Sci USA 1999;96(7):3842-3847.
84. Brent L, Kilshaw PJ: Prolongation of skin allograft survival with spleen extracts and antilymphocytic serum. Nature 1970;227(5261):898-900.
85. Kilshaw PJ, Brent L, Thomas AV: Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum. Transplantation 1974;17(1):57-69.
86. Waldmann H, Cobbold S: Regulating the immune response to transplants. a role for CD4+ regulatory cells? Immunity 2001;14(4):399-406.
87. Mizobuchi T, Yasufuku K, Zheng Y, et al: Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 2003;171(3):1140- 1147.
88. Mason D: A very high level of crossreactivity is an essential feature of the T cell receptor. Immunol Today 1998;19(9):395-404.
89. Cortesini R, Suciu-Foca N: The concept of "partial" clinical tolerance. Transpl Immunol 2004;13(2):101-104.
90. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3(3):199-210.
91. Zhai Y, Kupiec-Weglinski JW: What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 1999;11(5):497-503.
92. Guillonneau C, Aubry V, Renaudin K, et al: Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade. Transplantation 2005;80(2):255-263.
93. Koksoy S, Elpek KG, Yolcu ES, Shirwan H: Tolerance to rat heart grafts induced by intrathymic immunomodulation is mediated by indirect recognition primed CD4+CD25+ Treg cells. Transplantation 2005;79(11):1492-1497.
94. van Maurik A, Herber M, Wood KJ, Jones ND: Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002;169(10):5401-5404.
95. Piccirillo CA, Shevach EM: Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001;167(3):1137-1140.
96. Lin CY, Graca L, Cobbold SP, Waldmann H: Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat Immunol 2002;3(12):1208-1213.
97. Sanchez-Fueyo A, Weber M, Domenig C, Strom TB, Zheng XX: Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002;168(5):2274-2281.
98. Ng WF, Duggan PJ, Ponchel F, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001;98(9):2736- 2744.
99. Koenen HJ, Fasse E, Joosten I: IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 2003;171(12):6431-6441.
100. Taylor PA, Lees CJ, Blazar BR: The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99(10):3493-3499.
101. Iellem A, Mariani M, Lang R, et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001;194(6):847-853.
102. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW: Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005;201(7):1037-1044.
103. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG: B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001;2(12):1126-1132.
104. Holan V, Mitchison NA: Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur J Immunol 1983;13(8):652-657.
105. Madsen JC, Superina RA, Wood KJ, Morris PJ: Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988;332(6160):161-164.
106. Wong W, Morris PJ, Wood KJ: Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft. Transplantation 1996;62(10):1462-1468.
107. Saitovitch D, Morris PJ, Wood KJ: Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules. Transplantation 1996;61(10):1532-1538.
108. Sonntag KC, Emery DW, Yasumoto A, et al. Tolerance to solid organ transplants through transfer of MHC class II genes. J Clin Invest 2001;107(1):65-71.
109. Wong W, Morris PJ, Wood KJ: Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation 1997;63(10):1490-1494.
110. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H: T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996;156(10):3602-3607.
111. Banchereau J, Briere F, Caux C, et al: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
112. Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001;19:47-64.
113. Manavalan JS, Rossi PC, Vlad G, et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003;11(3-4):245-258.
114. Vlad G, Cortesini R, Suciu-Foca N: License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 2005;174(10):5907-5914.
115. Gallucci S, Matzinger P: Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13(1):114-119.
116. Matzinger P. The danger model: a renewed sense of self. Science 2002;296(5566):301-305.
117. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392(6673):245-252.
118. Colonna M, Trinchieri G, Liu YJ: Plasmacytoid dendritic cells in immunity. Nat Immunol 2004;5(12):1219-1226.
119. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002;99(1):351-358.
120. Chieppa M, Bianchi G, Doni A, et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 2003;171(9):4552-4560.
121. Penna G, Adorini L: 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164(5):2405-2411.
122. Liu Z, Tugulea S, Cortesini R, Suciu-Foca N: Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol 1998;10(6):775-783.
123. Chang CC, Ciubotariu R, Manavalan JS, et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3(3):237-243.
124. Min WP, Zhou D, Ichim TE, et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003;170(3):1304-1312.
125. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190(7):995-1004.
126. Gershon RK: A disquisition on suppressor T cells. Transplant Rev 1975;26:170-185.
127. Kappler JW, Roehm N, Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 1987;49(2):273-280.
128. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993;259(5097):974-977.
129. Mekala DJ, Alli RS, Geiger TL: IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Proc Natl Acad Sci USA 2005;102(33):11817-11822.
130. Munn DH, Sharma MD, Mellor AL: Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 2004;172(7):4100-4110.
131. Fallarino F, Grohmann U, Hwang KW, et al: Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003;4(12):1206-1212.
132. Grohmann U, Orabona C, Fallarino F, et al: CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002;3(11):1097-1101.
133. Cederbom L, Hall H, Ivars F: CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000;30(6):1538-1543.
134. Halloran PF, Homik J, Goes N, et al: The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997;29(1-2):79-81.
135. Yoshizawa A, Ito A, Li Y, et al: The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 2005;37(1):37-39.
136. Meloni F, Vitulo P, Bianco AM, et al: Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 2004;77(5):762-766.
137. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH: Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 2003;14(6):1643-1651.
138. Burke CM, Theodore J, Dawkins KD, et al: Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984;86(6):824-829.
139. Reichenspurner H, Girgis RE, Robbins RC, et al: Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996;62(5):1467-1472; discussion 1472-1463.
140. Yousem SA, Burke CM, Billingham ME: Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985;16(9):911-923.
141. Smith MA, Sundaresan S, Mohanakumar T, et al: Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998;116(5):812-820.
142. SivaSai KS, Smith MA, Poindexter NJ, et al: Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 1999;67(8):1094-1098.
143. Lu KC, Jaramillo A, Mendeloff EN, et al: Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003;22(1):35-43.
144. Reznik SI, Jaramillo A, SivaSai KS, et al: Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001;1(3):228-235.
145. Jaramillo A, Smith MA, Phelan D, et al: Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999;67(8):1155-1161.
146. Haque MA, Mizobuchi T, Yasufuku K, et al: Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002;169(3):1542-1549.
147. Smith CR, Mohanakumar T, Shimizu Y, et al: Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 2000;69(2):294-299.
148. Sakaguchi S, Sakaguchi N: Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice. J Exp Med 1988;167(4):1479-1485.
149. Shi YF, Sahai BM, Green DR: Cyclosporin A inhibits activation-induced cell death in T cell hybridomas and thymocytes. Nature 1989;339(6226):625-626.
150. Demirkiran A, Kok A, Kwekkeboom J, Metselaar HJ, Tilanus HW, van der Laan LJ. Decrease of CD4+CD25+ T cells in peripheral blood after liver transplantation: association with immunosuppression. Transplant Proc 2005;37(2):1194-1196.
151. Ciancio G, Burke GW, Gaynor JJ, et al: A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring1. Transplantation 2005;80(4):457-465.
152. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L: Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001;167(4):1945-1953.
153. Battaglia M, Stabilini A, Roncarolo MG: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005;105(12):4743-4748.